- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07939191
Effect of Consuming Processed Meat Products With Reduced Sodium on Cardiometabolic Risk Biomarkers (InovC4Sa_RCT1)
Effects of Consuming Processed Meat Products With Improved Sodium on Profiles on Cardiometabolic Risk Biomarkers
This study aims to evaluate the acute effects of consuming traditional processed meat products with reduced sodium content on blood pressure and urinary sodium excretion in healthy adults.
The study will compare the effects of traditional products with reformulated versions containing 25% and 50% less sodium. The products under evaluation include traditional Portuguese processed meat products such as "alheira", "chouriça" and "butelo".
Participants will consume the different product formulations according to a controlled study protocol.
Blood pressure will be assessed, and urine samples will be collected over a 24-hour period to evaluate sodium excretion.
This study is part of a research project focused on developing healthier traditional meat products while preserving their characteristic sensory properties. The findings may contribute to a better understanding of the effects of sodium reduction in processed meat products on cardiovascular health.
Studieoversikt
Status
Detaljert beskrivelse
In Portugal, traditional processed meat products, are valued for their cultural and gastronomic significance. However, their sodium content may be a nutritional concern. Reformulating these products to reduce sodium content represents a potential strategy to improve their nutritional profile while preserving traditional food products.
The InovC4Sa project aims to develop healthier processed meat products through nutritional reformulation, including sodium reduction. The present clinical study focuses on evaluating the acute effects of consuming traditional processed meat products with different levels of sodium reduction.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Mara Rodrigues
- Telefonnummer: +351 273 330 950
- E-post: mara@unipb.pt
Studiesteder
-
-
-
Bragança, Portugal, 5300
- Rekruttering
- Escola Superior de Saúde - Instituto Politécnico de Bragança
-
Ta kontakt med:
- Mara Rodrigues
- Telefonnummer: +351 273 330 950
- E-post: mara@unipb.pt
-
Ta kontakt med:
- Juliana Almeida de Souza, PhD
- E-post: julianaalmeida@unipb.pt
-
Hovedetterforsker:
- Juliana Almeida de Souza, PhD
-
Hovedetterforsker:
- Vera Ferro Lebres, PhD
-
Hovedetterforsker:
- Mara Rodrigues, MS
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Adults aged 18 to 60 years.
- Male or female participants.
- Individuals willing to participate and able to provide written informed consent.
- Users of the Universidade Politécnica de Bragança (UPB) canteen.
Exclusion Criteria:
- Diagnosis of cardiovascular disease.
- Diagnosis of metabolic disease.
- Diagnosis of liver disease.
- Pregnancy.
- Breastfeeding. Use of medication that may interfere on blood pressure regulation.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Alheira Intervention Group
Participants assigned to this group will consume three different formulations of tradition meat product 1 "alheira" in a day meal: the traditional formulation, a formulation with a 25% reduction in sodium content, and a formulation with a 50% reduction in sodium content. Each participant will receive all three formulations in a randomized sequence, with 7 days washout periods between intervention periods. The other meals of the day and of the previous day are standardized for all participants. The other meals of the day and of the previous day are standardized for all participants. |
Participants will consume three formulations of traditional Portuguese alheira: a conventional formulation (traditional sodium content), a reformulated version with a 25% reduction in sodium content, and a reformulated version with a 50% reduction in sodium content. Sodium reduction is achieved through product reformulation, including partial replacement of sodium chloride with potassium chloride. Each formulation will be administered as a separate intervention during the crossover study, with washout periods between intervention periods. |
|
Eksperimentell: Chouriça Intervention Group
Participants assigned to this group will consume three different formulations of a traditional meat product 2 "Chouriça" in a day meal: the traditional formulation, a formulation with a 25% reduction in sodium content, and a formulation with a 50% reduction in sodium content. Each participant will receive all three formulations in a randomized sequence, with 7 days washout periods between intervention periods. |
Participants will consume three formulations of traditional Portuguese chouriça: a conventional formulation (traditional sodium content), a reformulated version with a 25% reduction in sodium content, and a reformulated version with a 50% reduction in sodium content. Sodium reduction is achieved through product reformulation, including partial replacement of sodium chloride with potassium chloride. Each formulation will be administered as a separate intervention during the crossover study, with washout periods between intervention periods. |
|
Eksperimentell: Butelo Intervention Group
Participants assigned to this group will consume three different formulations of tradition meat product 3 "butelo" in a day meal: the traditional formulation, a formulation with a 25% reduction in sodium content, and a formulation with a 50% reduction in sodium content. Each participant will receive all three formulations in a randomized sequence, with 7 days washout periods between intervention periods. The other meals of the day and of the previous day are standardized for all participants. |
Participants will consume three formulations of traditional Portuguese butelo: a conventional formulation (traditional sodium content), a reformulated version with a 25% reduction in sodium content, and a reformulated version with a 50% reduction in sodium content. Sodium reduction is achieved through product reformulation, including partial replacement of sodium chloride with potassium chloride. Each formulation will be administered as a separate intervention during the crossover study, with washout periods between intervention periods. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
24-hour urinary sodium excretion
Tidsramme: 24 hours following consumption of each intervention product
|
Assessment of 24-hour urinary sodium excretion following consumption of traditional and sodium-reduced processed meat products. |
24 hours following consumption of each intervention product
|
|
Changes in systolic and diastolic blood pressure following consumption of processed meat products with different sodium contents
Tidsramme: Before and 2 hours after consumption of each intervention product.
|
Assessment of systolic and diastolic blood pressure before and after consumption of traditional and sodium-reduced processed meat products. |
Before and 2 hours after consumption of each intervention product.
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- InovC4Sa_sodium
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .